AzTrials
AzTrials

No ConditionsMUSPIN-BNCT03723044

Multistability: Perception is Inspired by Noise

A study testing EEG and occulometry in people with No Conditions, run by University Hospital, Grenoble at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Some stimuli, such as sinusoidal networks in motion, or the best known, Necker's cube, are simple visual stimulations generating interpretations of unstable and oscillatory shapes or movements, mutually exclusive. Read more about this study

Who is it for?
Ages 18 to 55 yearsHealthy volunteers can take part
Conditions the study is for
No Conditions
What is being tested?
EEG and occulometry
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteFrance
Study dates
5 Jun 2020to May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Signed informed consent
  • Medical examination carried out before the participation in the research
  • Age between 18 and 55 years
  • Minimum level of studies
  • Obligation to join the social security system
  • normal or corrected vision normal

Who cannot join

  • Subject included in another clinical and / or therapeutic experimentation in progress
  • Major vision disorder
  • Past or current neurological or neuropsychiatric pathologies
  • History of cranial trauma with loss of consciousness.
  • Medication treatments likely to modulate brain activity: benzodiazepine, antidepressants, neuroleptics, lithium, etc.
  • Diabetes, cardiac pathology, immunodeficiency.
Show all 12Show fewer
  • Medication treatments likely to modulate the activity of the cardiovascular system.
  • History of abuse or recent ingestion of alcohol, hard drugs or doping products.
  • Consumption of more than 15 cigarettes per day
  • Subject deprived of liberty by a judicial or administrative decision (L1121-6 CSP)
  • Major subject subject to a legal protection measure or unable to express their consent (L1121-8 CSP)
  • Pregnant, parturient and nursing mothers (L1121-5)

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • CHU Grenoble-Alpes

    Grenoble, 38043

    Anne GUERIN

    Laurent VERCUEIL

    Recruiting

Other trials in France

About this study

Some stimuli, such as sinusoidal networks in motion, or the best known, Necker's cube, are simple visual stimulations generating interpretations of unstable and oscillatory shapes or movements, mutually exclusive. Currently, the explanatory models of these perception phenomena are based on adaptation and learning mechanisms as well as the importance of noise in the perceptual and decision-making system. Often noise is a harmful component, but it can also be a facilitator in perceptual systems: the investigator's eye is always in motion, it is the micro-movements during eye fixation (phase of eye stability). In particular, the role of micro-eye movements has been identified in perceptual systems, and it will be necessary here to relate these micro-movements to the perceptive tilts facing multisable stimuli. However, how to access the perceptive states is a real question, since it has been shown that the participant's transfer of his perceptual state by means of a motor response can alter the very state of the percept. This is why the EEG activity will be analyzed to learn to discriminate the different percepts over time, without disruption of the participant's perceptual exploration endogenous activity.

Read the detailed description

Each participant will benefit from a medical interview before inclusion to eliminate the contraindications to this study. The maximum duration of the individual participation of each subject in this study is 5 hours in two sessions. Each session lasts 2h30. Both sessions are spaced a maximum of 14 days apart. Each session includes EEG headset placement and oculometer calibration (20 min), followed by recording EEG and eye tracking activity during a visual cognitive task where the participant will be presented with multi-stable visual stimuli to watch. for one or two minutes after the tests. By repeating the essays and the conditions of presentation, each session will be organized in six blocks of 20 minutes each, interspersed with a break.

Conditions
No Conditions
Being tested
EEG and occulometry
Keywords
Multistable Perception, Micro eye movement, Electroencephalography

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EEG and occulometryOther

    Each participants will spend two sessions of EEG and occulometry during a visual cognitive task where she/her will be presented with multi-stable visual stimuli to gaze at for one or two minutes. Depending on the experimental conditions, the participant will provide or not her/his perceptual state (i.e. which stimulus has been perceived ).

Study groups in NCT03723044
Study groupRoleWhat they receive
healthy volunteersExperimentalNot described
Receives: Other: EEG and occulometry

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Micro-eye movement

    Eye movements will be recorded with an eye-tracker : the continuous gaze position at each sampling period (1ms)

    Measured: along the complete experiment (2 hours) per session and per participant.

  2. Electroencephalography

    EEG will be recorded with 64 scalp electrodes (sampling rate 1kHz) with alpha and gamma waveform to found synchronuous neural correlates with the peceptive changes.

    Measured: along the complete experiment (2 hours) per session and per participant.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Oct 2018
  2. Study start5 Jun 2020
  3. Primary completionMay 2025 (estimated)
  4. Study completionMay 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03723044
Sponsor's protocol ID
38RC18.059
Acronym
MUSPIN-B
Status last verified
Jan 2024
First submitted
22 Oct 2018
Last updated
17 Jan 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing EEG and occulometry in people with No Conditions, run by University Hospital, Grenoble at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Anne Guerin, PhD (4 76 57 43 73 ext. 0033, anne.guerin@gipsa-lab.grenoble-inp.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Micro-eye movement (time frame: along the complete experiment (2 hours) per session and per participant.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jan 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in